Stage IVB Rectal Cancer Completed Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02041481MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal CancerTreatment
NCT00060411A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerTreatment
NCT00084643GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsTreatment